Change search
ReferencesLink to record
Permanent link

Direct link
EAU Guidelines on Primary Urethral Carcinoma
Show others and affiliations
2013 (English)In: European Urology, ISSN 0302-2838, E-ISSN 1873-7560, Vol. 64, no 5, 823-830 p.Article in journal (Refereed) Published
Abstract [en]

Context: The European Association of Urology (EAU) Guidelines Group on Muscle-Invasive and Metastatic Bladder Cancer prepared these guidelines to deliver current evidence-based information on the diagnosis and treatment of patients with primary urethral carcinoma (UC).

Objective: To review the current literature on the diagnosis and treatment of patients with primary UC and assess its level of scientific evidence.

Evidence acquisition: A systematic literature search was performed to identify studies reporting urethral malignancies. Medline was searched using the controlled vocabulary of the Medical Subject Headings database, along with a free-text protocol.

Evidence synthesis: Primary UC is considered a rare cancer, accounting for <1% of all malignancies. Risk factors for survival include age, tumour stage and grade, nodal stage, presence of distant metastasis, histologic type, tumour size, tumour location, and modality of treatment. Pelvic magnetic resonance imaging is the preferred method to assess the local extent of urethral tumour; computed tomography of the thorax and abdomen should be used to assess distant metastasis. In localised anterior UC, urethra-sparing surgery is an alternative to primary urethrectomy in both sexes, provided negative surgical margins can be achieved. Patients with locally advanced UC should be discussed by a multidisciplinary team of urologists, radiation oncologists, and oncologists. Patients with noninvasive UC or carcinoma in situ of the prostatic urethra and prostatic ducts can be treated with a urethra-sparing approach with transurethral resection and bacillus Calmette-Guerin (BCG). Cystoprostatectomy with extended pelvic lymphadenectomy should be reserved for patients not responding to BCG or as a primary treatment option in patients with extensive ductal or stromal involvement.

Conclusions: The 2013 guidelines document on primary UC is the first publication on this topic by the EAU. It aims to increase awareness in the urologic community and provide scientific transparency to improve outcomes of this rare urogenital malignancy.

Place, publisher, year, edition, pages
Elsevier, 2013. Vol. 64, no 5, 823-830 p.
Keyword [en]
Urethral carcinoma, Primary, Urethral neoplasms, Squamous cell carcinoma, Cytology, Cystoscopy, MRI, Biopsy, Urethral stricture, Penile-preserving surgery, Urethra-sparing surgery, Chemotherapy, Radiotherapy, EAU, Guidelines
National Category
Urology and Nephrology
URN: urn:nbn:se:umu:diva-82796DOI: 10.1016/j.eururo.2013.03.044ISI: 000325478100031OAI: diva2:663602
Available from: 2013-11-12 Created: 2013-11-11 Last updated: 2013-11-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Sherif, Amir M.
By organisation
Urology and Andrology
In the same journal
European Urology
Urology and Nephrology

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 57 hits
ReferencesLink to record
Permanent link

Direct link